Business / Finance

RSS
Genzyme, Sanofi-Aventis enter confidentiality agreement

Genzyme, Sanofi-Aventis enter confidentiality agreement

Court rules in favor of Volcano/Axsun against LightLab Imaging

Court rules in favor of Volcano/Axsun against LightLab Imaging

Masimo amends January 2006 settlement agreement with Covidien

Masimo amends January 2006 settlement agreement with Covidien

Duke, LifePoint enter joint venture to improve healthcare delivery for North Carolina community hospitals

Duke, LifePoint enter joint venture to improve healthcare delivery for North Carolina community hospitals

Quest Diagnostics to repurchase 15.4M shares from GSK affiliate

Quest Diagnostics to repurchase 15.4M shares from GSK affiliate

Valeant announces binding agreement to acquire PharmaSwiss for euro 350 million

Valeant announces binding agreement to acquire PharmaSwiss for euro 350 million

Parker Tennessee accepts to purchase common stock of King Pharmaceuticals at $14.25 per share

Parker Tennessee accepts to purchase common stock of King Pharmaceuticals at $14.25 per share

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Alexion announces acquisition of Taligen Therapeutics

Alexion announces acquisition of Taligen Therapeutics

Jiangsu Aosaikang Pharmaceutical to take 5% equity position in Living Cell Technologies

Jiangsu Aosaikang Pharmaceutical to take 5% equity position in Living Cell Technologies

Caraco generates $40.4 million and $268.2 million in third quarter, first nine months of Fiscal Year 2011

Caraco generates $40.4 million and $268.2 million in third quarter, first nine months of Fiscal Year 2011

Capital Pro-Égaux shares to continue on NEX

Capital Pro-Égaux shares to continue on NEX

Angiotech commences CCAA proceedings to implement pre-packaged financial restructuring

Angiotech commences CCAA proceedings to implement pre-packaged financial restructuring

National Mentor Holdings prices 12.50% senior notes due 2018

National Mentor Holdings prices 12.50% senior notes due 2018

European Commission grants approval for Johnson & Johnson's proposed acquisition of Crucell

European Commission grants approval for Johnson & Johnson's proposed acquisition of Crucell

Angiotech to continue implementation of previously announced recapitalization transaction under CCAA

Angiotech to continue implementation of previously announced recapitalization transaction under CCAA

Viral Genetics enters binding Release and Settlement Agreement with T&T

Viral Genetics enters binding Release and Settlement Agreement with T&T

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

PHM announces financial results for quarter and year ended September 30, 2010

PHM announces financial results for quarter and year ended September 30, 2010

Bionovo prices public offering of common stock at $1.30 per share

Bionovo prices public offering of common stock at $1.30 per share